AstraZeneca profit rises as cancer drug sales grow

AstraZeneca’s net profit jumped 45% in 2025, driven by strong cancer drug sales and expansion into the US and China markets, the company reports.

Read More: https://punchng.com/astrazeneca-profit-rises-as-cancer-drug-sales-grow/